IL-6 is involved in systemic features of COPD, such as muscle weakness and endothelial dysfunction (Bhowmik et al., 2000), while TNF-α is usually associated with airway inflammation through activation of the nuclear factor kappa B pathway (Kips et al., 1993). The gene discussed is TNF; the disease is endothelial dysfunction.